… , antagonists cc, natural cycle, adjuvant treatments , the success rates of … as growth hormone
present with enhanced clinical outcomes when compared to no adjuvant treatment in poor …

… (POR) remains one of the most challenging conditions in assisted reproduction technology.
… as poor responders according to different criteria, found that GH adjuvant therapy could help …

… participating in assisted reproductive technology (ART) programs. … with a history of poor
response during previous in vitro fertilization-… Adjuvant growth hormone treatment during in vitro …

… an adjuvant for in vitro fertilization (IVF) cycles in poor ovarian … received herbal drugs or
growth hormone and were excluded … Furthermore, although we used a GnRH antagonist protocol …

… reproductive technologies is estimated to be around 5–35% (Jenkins et al., 1991; Keay et al.,
… to a low-dose antagonist protocol did not show a detrimental effect on treatment outcome. …

… engaged in Assisted Reproductive Technology. Various … 2015 and underwent assisted
reproductive treatment in Yasmin … added Luteinizing hormones, Growth hormones and even …

… In assisted reproduction technologies (ART), such as in vitro fertilization (IVF), embryo … )
with placebo or no adjuvant treatment in women with RIF undergoing ART. Due to the lack of …

… GnRH antagonist use in poor responders found no significant … While assisted reproduction
techniques are becoming more … hormone pre-treatment or adjuvant therapies, specifically …

… protocol, but in some studies, flare-agonist and antagonist … of growth hormone adjuvant
therapy to the long down regulation protocol in poor responders undergoing in vitro fertilization: …

… women undergoing their first ART cycle with an antagonist protocol. According to the results
of our study, within the context of its limitations, a complete shift in clinical practice cannot be …